Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.47 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | PDK1 | Q15118 | 3/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.34 |
| ▸ | PDK3 | Q15120 | 3/20 | 0.34 |
| ▸ | PDK4 | Q16654 | 3/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.34 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | PYGL | P06737 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL803263 | 1.00 | TRPM8 (0.47) | TRPM8KDM4AKDM4CRORCPDK1 | |
| SCHEMBL785536 | 0.92 | TRPM8 (0.47) | TRPM8KDM4AKDM4CPDK2SLC6A4 | |
| SCHEMBL803766 | 0.92 | TRPM8 (0.47) | TRPM8KDM4AKDM4CPDK2SLC6A4 | |
| SCHEMBL803577 | 0.89 | TRPM8 (0.43) | TRPM8SLC6A4PIN1SLC6A2SLC6A3 | |
| SCHEMBL803768 | 0.88 | TRPM8 (0.43) | TRPM8KDM4AKDM4CPDK1PDK2 | |
| SCHEMBL784876 | 0.88 | TRPM8 (0.43) | TRPM8KDM4AKDM4CPDK1PDK2 | |
| SCHEMBL785967 | 0.87 | TRPM8 (0.47) | TRPM8PYGLNR1I2DRD3 | |
| SCHEMBL785968 | 0.87 | TRPM8 (0.47) | TRPM8PYGLNR1I2DRD3 | |
| SCHEMBL784506 | 0.84 | TRPM8 (0.41) | TRPM8KDM4AKDM4CPDK1PDK2 | |
| SCHEMBL784507 | 0.84 | TRPM8 (0.41) | TRPM8KDM4AKDM4CPDK1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680159-B2 | Bradykinin 1 receptor modulating compounds | GRUENENTHAL GMBH (DE) | 2014-03-25 | — | — | US | disclosed |
| US-20120071461-A1 | Substituted Benzamide Compounds | GRUENENTHAL GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071461-A1 | Substituted Benzamide Compounds | BDKRB1, BDKRB2, HRH2 | TRPM8 180/4885KDM4A 2438/4885KDM4C 2027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.